Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,536 | 81 | 78.1% |
| Education | $430.03 | 5 | 21.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $722.23 | 25 | $0 (2024) |
| UROVANT SCIENCES INC | $255.99 | 11 | $0 (2022) |
| Antares Pharma, Inc. | $184.75 | 8 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $141.17 | 9 | $0 (2023) |
| Myovant Sciences Inc. | $108.54 | 6 | $0 (2022) |
| PFIZER INC. | $77.36 | 5 | $0 (2024) |
| ABBVIE INC. | $63.67 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $60.07 | 3 | $0 (2024) |
| Axonics, Inc. | $58.74 | 3 | $0 (2023) |
| COLOPLAST CORP | $43.71 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $395.47 | 17 | Antares Pharma, Inc. ($184.75) |
| 2023 | $376.19 | 22 | Sumitomo Pharma America, Inc. ($141.17) |
| 2022 | $851.57 | 33 | Astellas Pharma US Inc ($377.28) |
| 2021 | $342.88 | 14 | Astellas Pharma US Inc ($239.64) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $109.37 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/16/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/25/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $34.70 | General |
| 09/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/28/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/13/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/24/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Men's Health | ||||||
| 06/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Oncology | ||||||
| 04/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Oncology | ||||||
| 03/11/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Urology | ||||||
| 11/06/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Urology | ||||||
| 10/18/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Oncology | ||||||
| 10/11/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: HORMONE THERAPY | ||||||
| 08/30/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Urology | ||||||
| 08/09/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 735 | 10,280 | $131,757 | $36,041 |
| 2022 | 9 | 888 | 7,726 | $144,650 | $39,354 |
| 2021 | 11 | 579 | 645 | $81,011 | $22,803 |
| 2020 | 8 | 602 | 7,627 | $92,509 | $20,939 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 236 | 360 | $57,600 | $18,293 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $12,410 | $3,369 | 27.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 16 | 17 | $12,705 | $3,225 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 49 | $11,662 | $3,141 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $10,516 | $2,897 | 27.6% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 17 | 21 | $6,681 | $1,674 | 25.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 160 | 208 | $11,648 | $1,435 | 12.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 155 | $3,100 | $1,302 | 42.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 43 | $1,763 | $357.29 | 20.3% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 11 | 9,305 | $2,792 | $197.29 | 7.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 44 | $880.00 | $150.04 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 238 | $38,080 | $12,756 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 113 | 113 | $41,245 | $11,009 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 125 | $29,750 | $9,051 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $14,818 | $3,699 | 25.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 159 | 214 | $11,984 | $1,557 | 13.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 151 | 178 | $3,560 | $527.46 | 14.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 81 | 95 | $1,900 | $323.27 | 17.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 32 | $1,312 | $291.08 | 22.2% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2022 | 14 | 6,669 | $2,001 | $141.13 | 7.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 107 | $25,466 | $8,415 | 33.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 120 | 138 | $22,080 | $7,461 | 33.8% |
| 74176 | Ct scan of abdomen and pelvis | Office | 2021 | 13 | 15 | $8,745 | $1,706 | 19.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,840 | $1,652 | 28.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $3,585 | $1,114 | 31.1% |
About Paul Morelli, P.A.-C
Paul Morelli, P.A.-C is a Medical healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821008970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Morelli, P.A.-C has received a total of $1,966 in payments from pharmaceutical and medical device companies, with $395.47 received in 2024. These payments were reported across 86 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,536).
As a Medicare-enrolled provider, Morelli has provided services to 2,804 Medicare beneficiaries, totaling 26,278 services with total Medicare billing of $119,137. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Athens, TX
- Active Since 08/09/2006
- Last Updated 04/16/2015
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1821008970
Products in Payments
- GEMTESA (Drug) $325.73
- XYOSTED (Drug) $184.75
- ORGOVYX (Drug) $179.97
- XTANDI (Drug) $162.01
- Myrbetriq (Drug) $109.67
- Xtandi (Drug) $97.88
- LUPRON DEPOT (Drug) $63.67
- Nubeqa (Drug) $60.07
- Axonics (Device) $58.74
- Titan (Device) $43.71
- AQUABEAM SYSTEM (Device) $40.51
- PROVENGE (Drug) $33.64
- UroLift System (Device) $25.98
- REZUM (Device) $20.17
- ELIGARD (Drug) $19.62
- OMNIGRAFT (Device) $17.89
- Prolia (Biological) $17.80
- ADVANTAGE (Device) $11.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Athens
Charles Davis, Pa, PA
Medical — Payments: $13,708
Anna Mcfather, Pa-C, PA-C
Medical — Payments: $11,736
Megan Duncan, Pa-C, PA-C
Medical — Payments: $7,409
Kayla Weaver
Medical — Payments: $6,268
Jonathan Nix, Pa, PA
Medical — Payments: $5,163
Joel Brooker, Pa-C, PA-C
Medical — Payments: $3,372